Deepinder Goyal faces Kunal Kamra’s jabs over 'Temple' claims

Founder of Eternal Deepinder Goyal is currently facing intense scrutiny from both the medical community and public commentators following the controversial defense of his latest venture, a health-tech wearable device named "Temple". 

The Rs 85,000 forehead-worn gadget claims to monitor real-time cerebral blood flow and generate a proprietary energy-expenditure metric called "Entropy". 

However, medical professionals have raised serious red flags regarding the lack of independent clinical validation, questioning whether sensors placed on superficial skin can accurately measure internal brain circulation. Consequently, Goyal issued a lengthy defense addressed to "Concerned Indian Doctors" on social media, which comedian Kunal Kamra has now dismantled through a series of satirical translations.

Instead of immediately providing peer-reviewed clinical data to quell the medical backlash, Goyal leaned heavily on his personal financial sacrifice and the company's generous return policy. Therefore, Kamra seized the opportunity to mock the CEO's defensive posture, pointing out that Goyal was substituting scientific evidence with sheer wealth and blind confidence. 

When the executive argued that a fraudulent company would not offer a 14-day, no-questions-asked return policy, Kamra bluntly translated the underlying logic to suggest that the company was essentially telling doctors to use their own time and resources to prove the device wrong. Furthermore, Goyal boasted about investing $20 million of his own money into the $30 million project. In response, the comedian quipped, "Give me Bharat Ratna & the Nobel Prize as I've put 2/3 of my own money behind my own idea".

Meanwhile, the dispute escalated as Goyal attempted to assert his philanthropic intentions. He stated that he had left a previous CEO role to chase purpose and possessed enough wealth to last for generations, insisting he was not staking his reputation to make a quick buck. Kamra, however, pierced through this corporate rhetoric, summarizing Goyal's stance as an admission that he would simply buy science if necessary because he has immense wealth. Similarly, when Goyal defended his company's cap table by noting that employees had invested in the round, Kamra brutally compared the situation to a pyramid scheme where workers are inherently in on the scam.

The core of the controversy remains rooted in the delayed release of independent clinical evidence. Goyal admitted that formal validations are still pending but claimed his team holds themselves to a higher standard with pre-prints coming soon. 

Kamra ridiculed this timeline, translating it as a demand for critics to shut up for the next eight to ten years while the company attempts to validate its product. Goyal stubbornly concluded that he believes in his own science and is confident the world will be astonished, telling doctors they can "keep raging". Consequently, Kamra characterised the former Zomato CEO's entire argument as a complete dismissal of scientific concerns in favor of shouting about his riches and unearned confidence.